Emanuela Oldoni

483 total citations
15 papers, 306 citations indexed

About

Emanuela Oldoni is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Emanuela Oldoni has authored 15 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Neurology and 4 papers in Physiology. Recurrent topics in Emanuela Oldoni's work include Alzheimer's disease research and treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Multiple Sclerosis Research Studies (3 papers). Emanuela Oldoni is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Multiple Sclerosis Research Studies (3 papers). Emanuela Oldoni collaborates with scholars based in Italy, Belgium and Spain. Emanuela Oldoni's co-authors include Elio Scarpini, An Goris, Daniela Galimberti, Koen Poesen, Milena De Riz, Anna M. Pietroboni, Chiara Fenoglio, Alberto Calvi, Maxim De Schaepdryver and Jos Tournoy and has published in prestigious journals such as Clinical Infectious Diseases, Annals of Neurology and Journal of Alzheimer s Disease.

In The Last Decade

Emanuela Oldoni

14 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emanuela Oldoni Italy 9 128 107 82 67 64 15 306
Huanyu Meng China 10 88 0.7× 125 1.2× 28 0.3× 40 0.6× 19 0.3× 28 280
Joseph H. Garcia United States 9 152 1.2× 83 0.8× 16 0.2× 67 1.0× 51 0.8× 34 360
Yvan Nicaise France 10 275 2.1× 41 0.4× 19 0.2× 47 0.7× 83 1.3× 19 448
Nicoletta Nuzziello Italy 9 233 1.8× 60 0.6× 43 0.5× 176 2.6× 16 0.3× 14 352
Claudio Derada Troletti Netherlands 7 147 1.1× 32 0.3× 34 0.4× 61 0.9× 43 0.7× 7 333
Evica Dinčić Serbia 11 78 0.6× 44 0.4× 134 1.6× 39 0.6× 38 0.6× 39 346
Hannah E. Salapa Canada 13 347 2.7× 56 0.5× 57 0.7× 25 0.4× 17 0.3× 27 421
Yugong Feng China 12 116 0.9× 119 1.1× 16 0.2× 49 0.7× 15 0.2× 69 316
Riccardo Berutti Germany 12 215 1.7× 137 1.3× 25 0.3× 25 0.4× 42 0.7× 29 502
Deepa Jonnalagadda United States 9 199 1.6× 21 0.2× 49 0.6× 23 0.3× 43 0.7× 15 391

Countries citing papers authored by Emanuela Oldoni

Since Specialization
Citations

This map shows the geographic impact of Emanuela Oldoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Oldoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Oldoni more than expected).

Fields of papers citing papers by Emanuela Oldoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Oldoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Oldoni. The network helps show where Emanuela Oldoni may publish in the future.

Co-authorship network of co-authors of Emanuela Oldoni

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Oldoni. A scholar is included among the top collaborators of Emanuela Oldoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Oldoni. Emanuela Oldoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Oldoni, Emanuela, Antón Ussi, Antoni L. Andreu, & David A. Morrow. (2023). It is time we got more personal with advanced therapies- How do we create the right ecosystem for more effective ATMP development in Europe?. Medical Research Archives. 11(9).
2.
Oldoni, Emanuela, Gary Saunders, Florence Biétrix, et al.. (2022). Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: A workshop report. Frontiers in Molecular Biosciences. 9. 974799–974799. 12 indexed citations
3.
Oldoni, Emanuela, Chiara Gerardi, Rita Banzi, et al.. (2022). Evaluating Translational Methods for Personalized Medicine—A Scoping Review. Journal of Personalized Medicine. 12(7). 1177–1177. 6 indexed citations
4.
Corradi, Domenico, Jeffrey E. Saffitz, Deborah Novelli, et al.. (2020). Prospective Evaluation of Clinico-Pathological Predictors of Postoperative Atrial Fibrillation. Circulation Arrhythmia and Electrophysiology. 13(8). e008382–e008382. 9 indexed citations
5.
Oldoni, Emanuela, Ide Smets, Marijne Vandebergh, et al.. (2020). CHIT1 at Diagnosis Reflects Long‐Term Multiple Sclerosis Disease Activity. Annals of Neurology. 87(4). 633–645. 27 indexed citations
6.
Oldoni, Emanuela, Alain J. van Gool, Laura García‐Bermejo, et al.. (2020). Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination. Clinical Infectious Diseases. 72(10). 1838–1842. 3 indexed citations
7.
Banzi, Rita, Chiara Gerardi, Maddalena Fratelli, et al.. (2020). Methodological approaches for personalised medicine: protocol for a series of scoping reviews. Zenodo (CERN European Organization for Nuclear Research). 3 indexed citations
8.
Gille, Benjamin, Maxim De Schaepdryver, Lieselot Dedeene, et al.. (2018). Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. Neuropathology and Applied Neurobiology. 45(3). 291–304. 90 indexed citations
9.
Fenoglio, Chiara, Emanuela Oldoni, María Serpente, et al.. (2018). LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients. Journal of Neuroimmunology. 324. 129–135. 40 indexed citations
10.
Dominici, Roberto, Dario Finazzi, Letizia Polito, et al.. (2018). Comparison of β2-microglobulin serum level between Alzheimer’s patients, cognitive healthy and mild cognitive impaired individuals. Biomarkers. 23(6). 603–608. 20 indexed citations
11.
Pietroboni, Anna M., Tiziana Carandini, Marta Scarioni, et al.. (2018). CSF β-amyloid predicts prognosis in patients with multiple sclerosis. Multiple Sclerosis Journal. 25(9). 1223–1231. 25 indexed citations
12.
Serpente, María, Chiara Fenoglio, Emanuela Oldoni, et al.. (2018). Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer’s Disease Patients. Journal of Alzheimer s Disease. 61(4). 1289–1294. 2 indexed citations
13.
Vigna, Luisella, Fabrizia Bamonti, Marina Arcaro, et al.. (2017). Effects of 1-month R-α-lipoic acid supplementation on humans oxidative status: a pilot study. Progress in nutrition. 19(1). 14–25. 2 indexed citations
14.
Fenoglio, Chiara, Milena De Riz, Anna M. Pietroboni, et al.. (2016). Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis. Journal of Neuroimmunology. 299. 81–83. 31 indexed citations
15.
Pietroboni, Anna M., Francesca Schiano di Cola, Marta Scarioni, et al.. (2016). CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Multiple Sclerosis Journal. 23(8). 1085–1091. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026